Roche Advances 'One Roche' Digital Health Strategy in China
Roche is implementing its "One Roche" approach in China to integrate pharmaceutical, diagnostics, and digital health capabilities into an end-to-end patient care solution.
Stocks · News reference
DAT Freight & Analytics, a subsidiary of Roper Technologies, has announced its role as a fuel sponsor for the 2026 Wreaths Across America Escort to Arlington convoy.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Roche is implementing its "One Roche" approach in China to integrate pharmaceutical, diagnostics, and digital health capabilities into an end-to-end patient care solution.
Roche Pharma Vietnam is collaborating with local health authorities and the City Cancer Challenge Foundation to support the development of a comprehensive breast cancer action plan in Danang.
ProShares S&P Technology Dividend Aristocrats ETF (TDV) is a smart beta ETF with $270.5 million in assets that tracks technology companies with dividend aristocrat status. The fund has delivered strong performance with 17.89% year-to-date returns and 20.67% one-year returns, though it carries higher volatility (beta of 1.13) and concentration risk with only 38 holdings. The 0.45% expense ratio is competitive, and the fund offers dividend yield of 1.06%, making it suitable for investors seeking technology exposure with dividend focus.
The U.S. Food and Drug Administration has approved Roche's new breast cancer medication, Wilserdly (giredestrant), for use in combination with Novartis's Afinitor.
Roche has secured FDA De Novo authorization for its cobas® pro i 601 platform integrated with the Ionify® Gabapentin assay.
Roche Diagnostics has made its Endotrophin (ETP) research prototype assay available on its cobas e801 analyzers at Nordic Bioscience's CLIA laboratory.